In a world first, scientists used CRISPR to fix a baby's unique genetic mutation. The report offers hope for personalized ...

Elizabeth Holmes had more resources, talent, and opportunity than most founders will ever see — and she blew it. Now, writes ...

A top agency official is meeting with industry and FDA staff as he works on guidance clarifying the FDA’s expectations for ...

Republicans on the House Appropriations Committee lauded the Make America Healthy Again movement on Wednesday while pushing ...

Lurking beneath the shiny promise of artificial intelligence in health care is a host of potential liability issues, experts ...

Good morning! Despite believing that headlines on STAT stories are “terrible,” former FDA head Robert Califf said at ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

CMS and ASTP, the health department’s health IT regulator, released a request for information this week about existing ...

The health of Native American communities is under threat because of massive cuts to federal health services, tribal leaders ...

Biotech investors are preparing for what may be the most important clinical trial readout for them this summer.

Lowering drug prices to European benchmarks would ultimately reduce innovation and cost American consumers just over half a ...

In hours of combative congressional hearings Wednesday, health secretary Robert F. Kennedy Jr. swung between defending ...